Majdnem totális (95%-os) pancreasresectiót követö pancreatogen diabetes kezelése Langerhans-sziget autotranszplantációval.

Translated title of the contribution: Management of diabetes induced by nearly total (95%) pancreatectomy with autologous transplantation of Langerhans cells

G. Farkas, A. Pap

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The present report concerns a patient who had undergone nearly total pancreatectomy (95%) with pancreatic islet autotransplantation for intractable pain caused by obstructive chronic pancreatitis. Islets were prepared by a modified collagenase digestion and were cultured in vitro in Eagel's medium in 5% CO2 in air at 37 degrees C for 5 days. The resultant preparation, containing about 150,000 islets, was injected into the recipient's liver via the umbilical vein. No complication occurred from the pancreatectomy or transplant. Postoperatively, the patient had complete relief of the abdominal pain, and the insulin-independent condition remained with normal fasting blood glucose, and hemoglobin A1c for 11 months. Subsequently the fasting hyperglycemia was evident, and the patient began oral antidiabetic medication, but 2 year after transplantation the insulin-dependent condition demanded exogenous insulin (24 U). At present the fasting serum C-peptide level is 0.6 ng/ml and the HbA1c of 5.8% confirms the normoglycemic condition at the same insulin dose. Islet auto-transplantation should be considered as an adjunct procedure to prevent or ameliorate diabetes after total or nearly total pancreatic resection.

Original languageHungarian
Pages (from-to)1863-1867
Number of pages5
JournalOrvosi Hetilap
Volume138
Issue number29
Publication statusPublished - Jul 20 1997

Fingerprint

Pancreatectomy
Langerhans Cells
Autologous Transplantation
Insulin
Fasting
Intractable Pain
Islets of Langerhans Transplantation
Umbilical Veins
C-Peptide
Chronic Pancreatitis
Collagenases
Islets of Langerhans
Hypoglycemic Agents
Hyperglycemia
Abdominal Pain
Blood Glucose
Digestion
Hemoglobins
Transplantation
Air

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Majdnem totális (95%-os) pancreasresectiót követö pancreatogen diabetes kezelése Langerhans-sziget autotranszplantációval. / Farkas, G.; Pap, A.

In: Orvosi Hetilap, Vol. 138, No. 29, 20.07.1997, p. 1863-1867.

Research output: Contribution to journalArticle

@article{06ea17869f3643aa928ada8ef5e4c1b4,
title = "Majdnem tot{\'a}lis (95{\%}-os) pancreasresecti{\'o}t k{\"o}vet{\"o} pancreatogen diabetes kezel{\'e}se Langerhans-sziget autotranszplant{\'a}ci{\'o}val.",
abstract = "The present report concerns a patient who had undergone nearly total pancreatectomy (95{\%}) with pancreatic islet autotransplantation for intractable pain caused by obstructive chronic pancreatitis. Islets were prepared by a modified collagenase digestion and were cultured in vitro in Eagel's medium in 5{\%} CO2 in air at 37 degrees C for 5 days. The resultant preparation, containing about 150,000 islets, was injected into the recipient's liver via the umbilical vein. No complication occurred from the pancreatectomy or transplant. Postoperatively, the patient had complete relief of the abdominal pain, and the insulin-independent condition remained with normal fasting blood glucose, and hemoglobin A1c for 11 months. Subsequently the fasting hyperglycemia was evident, and the patient began oral antidiabetic medication, but 2 year after transplantation the insulin-dependent condition demanded exogenous insulin (24 U). At present the fasting serum C-peptide level is 0.6 ng/ml and the HbA1c of 5.8{\%} confirms the normoglycemic condition at the same insulin dose. Islet auto-transplantation should be considered as an adjunct procedure to prevent or ameliorate diabetes after total or nearly total pancreatic resection.",
author = "G. Farkas and A. Pap",
year = "1997",
month = "7",
day = "20",
language = "Hungarian",
volume = "138",
pages = "1863--1867",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "29",

}

TY - JOUR

T1 - Majdnem totális (95%-os) pancreasresectiót követö pancreatogen diabetes kezelése Langerhans-sziget autotranszplantációval.

AU - Farkas, G.

AU - Pap, A.

PY - 1997/7/20

Y1 - 1997/7/20

N2 - The present report concerns a patient who had undergone nearly total pancreatectomy (95%) with pancreatic islet autotransplantation for intractable pain caused by obstructive chronic pancreatitis. Islets were prepared by a modified collagenase digestion and were cultured in vitro in Eagel's medium in 5% CO2 in air at 37 degrees C for 5 days. The resultant preparation, containing about 150,000 islets, was injected into the recipient's liver via the umbilical vein. No complication occurred from the pancreatectomy or transplant. Postoperatively, the patient had complete relief of the abdominal pain, and the insulin-independent condition remained with normal fasting blood glucose, and hemoglobin A1c for 11 months. Subsequently the fasting hyperglycemia was evident, and the patient began oral antidiabetic medication, but 2 year after transplantation the insulin-dependent condition demanded exogenous insulin (24 U). At present the fasting serum C-peptide level is 0.6 ng/ml and the HbA1c of 5.8% confirms the normoglycemic condition at the same insulin dose. Islet auto-transplantation should be considered as an adjunct procedure to prevent or ameliorate diabetes after total or nearly total pancreatic resection.

AB - The present report concerns a patient who had undergone nearly total pancreatectomy (95%) with pancreatic islet autotransplantation for intractable pain caused by obstructive chronic pancreatitis. Islets were prepared by a modified collagenase digestion and were cultured in vitro in Eagel's medium in 5% CO2 in air at 37 degrees C for 5 days. The resultant preparation, containing about 150,000 islets, was injected into the recipient's liver via the umbilical vein. No complication occurred from the pancreatectomy or transplant. Postoperatively, the patient had complete relief of the abdominal pain, and the insulin-independent condition remained with normal fasting blood glucose, and hemoglobin A1c for 11 months. Subsequently the fasting hyperglycemia was evident, and the patient began oral antidiabetic medication, but 2 year after transplantation the insulin-dependent condition demanded exogenous insulin (24 U). At present the fasting serum C-peptide level is 0.6 ng/ml and the HbA1c of 5.8% confirms the normoglycemic condition at the same insulin dose. Islet auto-transplantation should be considered as an adjunct procedure to prevent or ameliorate diabetes after total or nearly total pancreatic resection.

UR - http://www.scopus.com/inward/record.url?scp=0031580219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031580219&partnerID=8YFLogxK

M3 - Article

C2 - 9280885

AN - SCOPUS:0031580219

VL - 138

SP - 1863

EP - 1867

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 29

ER -